Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Labetalol hydrochloride
RPH Pharmaceuticals AB
C07AG; C07AG01
Labetalol hydrochloride
5 milligram(s)/millilitre
Solution for injection
Product subject to prescription which may not be renewed (A)
Alpha and beta blocking agents; labetalol
Marketed
1993-07-19
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT TRANDATE 5MG/ML SOLUTION FOR INJECTION labetalol hydrochloride READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4 WHAT IS IN THIS LEAFLET: 1. What Trandate injection is and what it is used for 2. What you need to know before you are given Trandate injection 3. How you will be given Trandate injection 4. Possible side effects 5. How to store Trandate injection 6. Contents of the pack and further information 1. WHAT TRANDATE INJECTION IS FOR In this leaflet Trandate 5 mg/ml Solution for Injection will be called Trandate injection. Trandate injection belongs to a group of medicines called beta blockers. Trandate injection works by causing the heart to beat more slowly and with less force. It also widens the arteries in the body. This helps to lower the pressure of the blood as it travels around the body. The result is a rapid lowering of a person’s blood pressure. Trandate injection is given in hospital and can be used to: • Lower very high blood pressure, especially in pregnant women • Keep your blood pressure down during an operation • Lower high blood pressure after a heart attack. It is very important that the doctor treats your high blood pressure, because left untreated it can cause damage to your blood vessels in the long-term. This could lead to heart attacks, kidney failure, stroke or blindness. 2. WHAT YOU NEED TO KNOW BEFORE YOU ARE GIVEN TRANDATE INJECTION DO NOT USE TRANDATE INJECTION : • if you are allergic to labetalol hydrochloride or any of the other ingredients of this medicine (listed in section 6 • if your heart cannot maintain adequate circulation of blood (cardiogenic shock) • if you have heart fa Read the complete document
Health Products Regulatory Authority 09 March 2023 CRN00DFXS Page 1 of 8 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Trandate 5mg/ml Solution for Injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of solution contains 5mg labetalol hydrochloride. For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Solution for injection A colourless or very pale yellow solution 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Trandate Injection is indicated for the treatment of:- 1. Severe hypertension, including severe hypertension of pregnancy, when rapid control of blood pressure is essential. 2. Anaesthesia when a hypotensive technique is indicated. 3. Hypertensive episodes following acute myocardial infarction. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _ADULTS:_ Trandate Injection is intended for intravenous use in hospitalised patients. The plasma concentrations achieved after intravenous dose of Trandate in severe hypertension are substantially greater than those following oral administration of the drug and provide a greater degree of blockade of alpha-adrenoceptors necessary to control the more severe disease. Patients should, therefore, always receive the drug whilst in the supine or left lateral position. Raising the patient into the upright position, within three hours of intravenous Trandate administration, should be avoided since excessive postural hypotension may occur. _BOLUS INJECTION_ If it is essential to reduce blood pressure quickly, as for example, in hypertensive encephalopathy, a dose of 50mg of Trandate should be given by intravenous injection over a period of at least one minute. If necessary, doses of 50mg may be repeated at five minute intervals until a satisfactory response occurs. The total dose should not exceed 200mg. After bolus injection, the maximum effect usually occurs within five minutes and the effective duration of action is usually about six hours but may be as long as eighteen hours. _INTRAVENOUS INFUSION_ An alternative method Read the complete document